Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Antimicrobial Resistance & Infection Control
Published in: Antimicrobial Resistance & Infection Control 1/2012

Open Access 01-12-2012 | Short report

USA300 Methicillin-resistant Staphylococcus aureus in Cuba

Authors: Joost Hopman, Gilda Toraño Peraza, Fidel Espinosa, Corné H Klaassen, Dayneris Menéndez Velázquez, Jacques F Meis, Andreas Voss

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2012

Login to get access

Abstract

Background

Methicillin-resistant Staphylococcus aureus is an increasing problem in the Caribbean. We investigated the molecular epidemiology of MRSA isolates on Cuba.

Findings

The predominant clone was of the spa type t149, followed by community-associated MRSA USA300.

Conclusions

We report the first molecular typing results of MRSA isolates from Cuba.
Literature
1.
Guzman-Blanco M, Mejia C, Isturiz R, Alvarez C, Bavestrello L, Gotuzzo E: Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Latin America. Int J Antimicrob Agents. 2009, 34: 304-308. 10.1016/j.ijantimicag.2009.06.005.CrossRefPubMed
2.
Izquierdo-Cubas F, Zambrano A, Frometa I, Gutierrez A, Bastanzuri M, Guanche H: National prevalence of nosocomial infections. Cuba 2004. J Hosp Infect. 2008, 68: 234-240. 10.1016/j.jhin.2007.12.006.CrossRefPubMed
3.
Reyes J, Rincon S, Diaz L, Panesso D, Contreras GA, Zurita J: Dissemination of methicillin-resistant Staphylococcus aureus USA300 sequence type 8 lineage in Latin America. Clin Infect Dis. 2009, 49: 1861-1867. 10.1086/648426.PubMedCentralCrossRefPubMed
4.
Rodriguez-Noriega E, Seas C, Guzman-Blanco M, Mejia C, Alvarez C, Bavestrello L: Evolution of methicillin-resistant Staphylococcus aureus clones in Latin America. Int J Infect Dis. 2010, 14: e560-e566. 10.1016/j.ijid.2009.08.018.CrossRefPubMed
5.
Freitas EA, Harris RM, Blake RK, Salgado CD: Prevalence of USA300 strain type of methicillin-resistant Staphylococcus aureus among patients with nasal colonization identified with active surveillance. Infect Control Hosp Epidemiol. 2010, 31: 469-475. 10.1086/651672.CrossRefPubMed
6.
Jain R, Kralovic SM, Evans ME, Ambrose M, Simbartl LA, Obrosky DS: Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med. 2011, 364: 1419-1430. 10.1056/NEJMoa1007474.CrossRefPubMed
7.
Allegranzi B, Bagheri NS, Combescure C, Graafmans W, Attar H, Donaldson L: Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet. 2011, 377: 228-241. 10.1016/S0140-6736(10)61458-4.CrossRefPubMed
8.
Rosenthal VD, Maki DG, Graves N: The International Nosocomial Infection Control Consortium (INICC): goals and objectives, description of surveillance methods, and operational activities. Am J Infect Control. 2008, 36: e1-12.CrossRefPubMed
9.
Pittet D, Allegranzi B, Storr J, Bagheri NS, Dziekan G, Leotsakos A: Infection control as a major World Health Organization priority for developing countries. J Hosp Infect. 2008, 68: 285-292. 10.1016/j.jhin.2007.12.013.CrossRefPubMed
10.
Guanche-Garcell H, Requejo-Pino O, Rosenthal VD, Morales-Perez C, gado-Gonzalez O, Fernandez-Gonzalez D: Device-associated infection rates in adult intensive care units of Cuban university hospitals: International Nosocomial Infection Control Consortium (INICC) findings. Int J Infect Dis. 2011, 15: e357-e362. 10.1016/j.ijid.2011.02.001.CrossRefPubMed
11.
Drain PK, Barry M: Global health. Fifty years of U.S. embargo: Cuba's health outcomes and lessons. Science. 2010, 328: 572-573. 10.1126/science.1189680.PubMedCentralCrossRefPubMed
Metadata
Title
USA300 Methicillin-resistant Staphylococcus aureus in Cuba
Authors
Joost Hopman
Gilda Toraño Peraza
Fidel Espinosa
Corné H Klaassen
Dayneris Menéndez Velázquez
Jacques F Meis
Andreas Voss
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2012
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/2047-2994-1-2

Other articles of this Issue 1/2012

Antimicrobial Resistance & Infection Control 1/2012 Go to the issue

Research

Prospective evaluation of the usefulness of C-reactive protein in the diagnosis of neonatal sepsis in a sub-Saharan African region

Editorial

Priority actions to fight antibiotic resistance: results of an international meeting

Research

Impact of a hospital-wide hand hygiene promotion strategy on healthcare-associated infections

Letter to the Editor

Specialist trainees on rotation cannot replace dedicated consultant clinicians for antimicrobial stewardship of specialty disciplines

Commentary

The gut is the epicentre of antibiotic resistance

Research

Impact of catheter antimicrobial coating on species-specific risk of catheter colonization: a meta-analysis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits